CancerDrs

Liver Cancer

Hepatocellular carcinoma (HCC) and related primary liver malignancies.

22%
5-year relative survival
U.S. average across all stages
197
recruiting trials
Active in the U.S. right now
42,240
new diagnoses / year
You are not alone — roughly 116 people per day
67
median age at diagnosis
Most diagnoses occur in adults over age 50

Source: NCI SEER + ClinicalTrials.gov

Liver Cancer by the numbers (U.S.)

42,240
Estimated new cases (2025)
30,090
Estimated deaths (2025)
22%
5-year relative survival
67
Median age at diagnosis

Source: NCI SEER Cancer Stat Facts

Liver Cancer clinical trials →

197 actively recruiting trials across the U.S., with filters by state.

FDA-approved drugs & cost →

Every FDA-approved therapy with liver cancer in its indications — mechanisms, Medicare spending per drug, manufacturer assistance.

Drug costs overview →

CMS Medicare spending data for 15 major oncology drugs — what patients and Medicare actually pay.

Second opinion for liver cancer →

Step-by-step for getting a virtual second opinion from a top cancer center.

NCI-designated cancer centers →

All 71 NCI cancer centers with hospital quality data and state browser.

Find a medical oncologist →

Licensed oncologists across every U.S. state, by specialty.

Financial aid resources →

Co-pay relief, drug patient-assistance, transportation, and lodging support.

Patient guides →

How to read a pathology report, questions to ask your oncologist, staging explained.

Also known as

HCC, hepatocellular carcinoma.

For deeper statistics

See the NCI SEER Cancer Stat Facts page: Liver Cancer on SEER →